A recent study supports the Center for Medicare Advocacy’s long-held concern about increasing out-of-pocket costs for Medicare beneficiaries. In summary, requiring beneficiaries to pay more of their own money will not make them savvier consumers; … [Read more...] about Study Finds Cost-Sharing Increases Can be Deadly
Medicare Part D / Prescription Drugs
Final 2022 Rule for Medicare Parts C and D Released By Trump Administration
I. Overview On February 18, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled “Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, … [Read more...] about Final 2022 Rule for Medicare Parts C and D Released By Trump Administration
Dismantling the Affordable Care Act Would Harm Medicare and Medicare Beneficiaries
Spotlight on Closing the Part D Coverage Gap (“Donut Hole”) The Supreme Court will review the constitutionality of the Affordable Care Act (ACA) this term in California v. Texas, with oral argument scheduled for November 10, 2020. This … [Read more...] about Dismantling the Affordable Care Act Would Harm Medicare and Medicare Beneficiaries
Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs
On September 9, 2020, U.S. Senators Bob Casey and Elizabeth Warren released a report entitled “Rapidly Increasing Postal Service Delivery Delays for Mail-Order.” The report focuses on recent operational changes made at the U.S. Postal Service (USPS) … [Read more...] about Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs
Center Letter Re: Impact of Postal Service Delays on Medicare Beneficiaries
September 3, 2020 VIA ELECTRONIC SUBMISSION The Honorable Robert P. Casey, Jr.United States Senate393 Russell Senate Office BuildingWashington, D.C. 20510 The Honorable Elizabeth WarrenUnited States Senate309 Hart Senate Office … [Read more...] about Center Letter Re: Impact of Postal Service Delays on Medicare Beneficiaries
Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks
On May 22, 2020, the Centers for Medicare & Medicaid Services (CMS) published a final rule regarding Medicare Advantage (Medicare Part C) and Part D prescription drug plans (“C & D Rule”). The rule is entitled “Medicare Program; Contract Year … [Read more...] about Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks
CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees
In a May 26, 2020 press release, the Centers for Medicare & Medicaid Services (CMS) “announced that over 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer … [Read more...] about CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees
Center for Medicare Advocacy Submits Comments on Proposed Medicare Parts C and D Rule
On February 18, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare … [Read more...] about Center for Medicare Advocacy Submits Comments on Proposed Medicare Parts C and D Rule
House Passes Historic Medicare Expansion Bill – H.R. 3
Today the U.S. House of Representatives passed H.R. 3, The Elijah Cummings Lower Drug Costs Now Act, by a vote of 230 to 192. This bill, if enacted into law, would lead to a significant reduction in prescription drug costs. The resulting savings … [Read more...] about House Passes Historic Medicare Expansion Bill – H.R. 3
Medicare Experts Call for Swift Passage of HR3 to Lower Drug Prices and Improve Medicare
For Immediate Release December 9, 2019 Contact: Kata Kertesz, Esq. – kkertesz@medicareadvocacy.org, 202-293-5760 The Center for Medicare Advocacy, leading Medicare beneficiary experts, call on Congress to pass groundbreaking legislation to … [Read more...] about Medicare Experts Call for Swift Passage of HR3 to Lower Drug Prices and Improve Medicare